Evidence map›Paper›PMID 14586494›Full record

Trial reportIntensive care medicine2004

Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Andrew J Johnston, Luzius A Steiner, Mark O'Connell, Dot A Chatfield, Arun K Gupta, David K Menon

Abstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Implementation and Evaluation of Weight-Based Vasopressors in Intensive Care Units.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2011
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrew J JohnstonUniversity of Cambridge Department of Anaesthetics, Addenbrooke's Hospital, Box 93, Cambridge, CB2 2QQ, United Kingdom. ajj29@cam.ac.uk
Luzius A Steiner
Mark O'Connell
Dot A Chatfield
Arun K Gupta
David K Menon
Addenbrooke's Hospital · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the pharmacokinetics and pharmacodynamics of dopamine and norepinephrine.

designProspective, controlled, trial.

settingNeurosciences critical care unit. PATIENTS: Eight patients with a head injury, requiring dopamine or norepinephrine infusions to support cerebral perfusion pressure (CPP).

interventionPatients received in randomised order, either dopamine or norepinephrine to achieve and maintain a CPP of 70 mmHg, and then, following a 30-min period of stable haemodynamics, a CPP of 90 mmHg. Data were then acquired using the second agent. Haemodynamic measurements were made during each period and a blood sample was obtained at the end of each study period for analysis of plasma catecholamine concentrations MEASUREMENTS AND

resultsPlasma levels of norepinephrine and dopamine were significantly related to infusion rates but did not have a simple linear relationship to haemodynamic parameters. However, there was a significant quadratic relationship between the infusion rate of dopamine and cardiac index (r2=0.431), and systemic vascular resistance index (r2=0.605), with a breakpoint (at which cardiac index reduced and SVRI increased) at a dopamine plasma level of approximately 50 nM/l (corresponding to an infusion rate of approximately 15 microg.kg(-1).min(-1)).

conclusionsNorepinephrine and dopamine have predictable pharmacokinetics; however, those of dopamine do not fit a simple first-order kinetic model. The pharmacodynamic effects of dopamine and norepinephrine show much inter-individual variability and unpredictability. Plasma levels of dopamine appear to relate to variations in adrenergic receptor effects with break points that reflect expectations from infusion-rate related pharmacodynamics.

Indexed as

DopamineNorepinephrineVasoconstrictor AgentsAdultCardiotonic AgentsCatecholaminesCraniocerebral TraumaCritical IllnessCross-Over StudiesDose-Response Relationship, DrugDrug MonitoringFemaleHeart RateHumansInfusions, IntravenousIntracranial PressureCardiotonic AgentsCatecholaminesDopamineNorepinephrineVasoconstrictor Agents

Identifiers

PMID14586494
OpenAlexW2057315402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.